182 related articles for article (PubMed ID: 26513219)
1. Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013.
Ng J; Ye F; Roth L; Sobel K; Byron S; Barton M; Lindley M; Stokley S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(42):1185-9. PubMed ID: 26513219
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus vaccination and cervical cancer screening coverage in managed care plans - United States, 2018.
Richards TB; Lindley MC; Byron SC; Saraiya M
Prev Med; 2022 Jun; 159():107019. PubMed ID: 35283162
[TBL] [Abstract][Full Text] [Related]
3. Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives From Commercial and Medicaid Health Plans.
Ng JH; Sobel K; Roth L; Byron SC; Lindley MC; Stokley S
J Public Health Manag Pract; 2017; 23(3):283-290. PubMed ID: 27798527
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of male HPV vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
[TBL] [Abstract][Full Text] [Related]
5. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
[TBL] [Abstract][Full Text] [Related]
6. Improving HPV vaccination rates.
Fiks AG;
LDI Issue Brief; 2014 Mar; 19(1):1-4. PubMed ID: 24660247
[TBL] [Abstract][Full Text] [Related]
7. Rationale for reducing the spread of human papillomavirus in adolescents: strategies to improve outcomes (CME multimedia activity).
Alexander K; Daley AM; Dempsey AF
J Adolesc Health; 2012 May; 50(5):IBC. PubMed ID: 22525122
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
Stokley S; Jeyarajah J; Yankey D; Cano M; Gee J; Roark J; Curtis RC; Markowitz L; ;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):620-4. PubMed ID: 25055185
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
11. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus disease in adolescents: management and prevention.
Widdice LE
Adolesc Med State Art Rev; 2012 Apr; 23(1):192-206, xii-xiii. PubMed ID: 22764563
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents.
Rand CM; Brill H; Albertin C; Humiston SG; Schaffer S; Shone LP; Blumkin AK; Szilagyi PG
J Adolesc Health; 2015 May; 56(5 Suppl):S17-20. PubMed ID: 25863549
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus-associated cancers - United States, 2004-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
[TBL] [Abstract][Full Text] [Related]
15. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
17. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
[TBL] [Abstract][Full Text] [Related]
19. Increasing human papillomavirus vaccination at the recommended age.
Lin X; Shrader L; Rodgers L; Stokley S; Markowitz LE
Vaccine; 2019 Jan; 37(5):686-689. PubMed ID: 30591254
[TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus vaccines.
Ljubojević S
Acta Dermatovenerol Croat; 2006; 14(3):208. PubMed ID: 17010274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
